{"ticker": {"uuid": "6db3efcc-42dc-4ee3-845c-2e546f3cbaf2", "symbol": "BBNX", "name": "Beta Bionics, Inc. Common Stock", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Medical Devices"}, "articles": [{"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Truist Raises Price Target on Beta Bionics to $22 From $18, Keeps Buy Rating", "summary": "Truist Securities has increased its price target for Beta Bionics (NASDAQ: BBLN) to $22 from $18, while reiterating a \"Buy\" rating on the stock. This adjustment suggests a positive outlook on the company's financial prospects and stock performance.", "url": "https://www.moomoo.com/news/post/72857299/truist-raises-price-target-on-beta-bionics-to-22-from?futusource=news_newspage_recommend", "source_name": "Moomoo", "published_at": "2026-07-14T14:13:43", "published_display": "14 Jul 2026 14:13", "sentiment": "positive", "sentiment_pct": 73, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "If You Invested $1,000 in Beta Bionics, Inc. (BBNX)", "summary": "This article analyzes the historical performance of Beta Bionics, Inc. (BBNX) stock, specifically calculating the return on a hypothetical $1,000 investment over different periods. It highlights that a $1,000 investment one year ago would now be worth $1,346, a 34.6% increase. Th", "url": "https://www.stocktitan.net/tools/stock-return-calculator/BBNX", "source_name": "Stock Titan", "published_at": "2026-07-14T14:13:43", "published_display": "14 Jul 2026 14:13", "sentiment": "positive", "sentiment_pct": 63, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ETFs Investing in Beta Bionics, Inc. Stocks", "summary": "This article lists several ETFs that invest in Beta Bionics, Inc. (BBNX) stocks, providing details such as market value, weight, issuer, expense ratio, and performance. The ETFs offer investors diversified exposure to the medical technology sector and small-cap companies, among o", "url": "https://www.tradingview.com/symbols/NASDAQ-BBNX/etfs/", "source_name": "TradingView", "published_at": "2026-07-07T20:13:13", "published_display": "07 Jul 2026 20:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Beta Bionics, Inc. \u2013 NASDAQ:BBNX", "summary": "This article focuses on the \"Price to earnings forward\" financial metric for Beta Bionics, Inc. (NASDAQ: BBNX) as reported by TradingView. The page displays the company's stock information, along with navigation to various financial and community features on the TradingView platf", "url": "https://www.tradingview.com/symbols/NASDAQ-BBNX/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-07-06T09:40:08", "published_display": "06 Jul 2026 09:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Beta Bionics, Inc. \u2013 NASDAQ:BBNX", "summary": "This article provides financial data for Beta Bionics, Inc. (NASDAQ: BBNX), specifically focusing on its enterprise value to EBITDA forward metric. The content appears to be a financial data snippet from TradingView, indicating the period, value, and change for this specific fina", "url": "https://www.tradingview.com/symbols/NASDAQ-BBNX/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-07-04T11:10:06", "published_display": "04 Jul 2026 11:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Beta Bionics CFO Stephen Feider sells $170k of BBNX stock", "summary": "Stephen Feider, CFO of Beta Bionics (NASDAQ:BBNX), sold 10,000 shares of company stock for a total of approximately $170,387 across two transactions in late June. These sales were made under a Rule 10b5-1 trading plan and occurred concurrently with the exercise of employee stock ", "url": "https://www.investing.com/news/insider-trading-news/beta-bionics-cfo-stephen-feider-sells-170k-of-bbnx-stock-93CH-4774658", "source_name": "Investing.com", "published_at": "2026-07-02T23:12:55", "published_display": "02 Jul 2026 23:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Beta Bionics to Announce Second Quarter 2026 Financial Results on July 29, 2026", "summary": "Beta Bionics, Inc. announced its plan to release second quarter 2026 financial results after market close on Wednesday, July 29, 2026. The company will host a conference call and webcast on the same day at 4:30 pm Eastern Time to discuss its performance. The webcast link and dial", "url": "https://www.manilatimes.net/2026/07/01/tmt-newswire/globenewswire/beta-bionics-to-announce-second-quarter-2026-financial-results-on-july-29-2026/2376712", "source_name": "The Manila Times", "published_at": "2026-07-02T10:40:42", "published_display": "02 Jul 2026 10:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Beta Bionics sets July 29 call for Q2 2026 results", "summary": "Beta Bionics (Nasdaq: BBNX) announced it will release its second quarter 2026 financial results after market close on Wednesday, July 29, 2026. Management will host a conference call and webcast on the same day at 4:30 pm ET to discuss the quarterly performance. The announcement ", "url": "https://www.stocktitan.net/news/BBNX/beta-bionics-to-announce-second-quarter-2026-financial-results-on-w0nxe80bjo0u.html", "source_name": "Stock Titan", "published_at": "2026-07-01T23:40:47", "published_display": "01 Jul 2026 23:40", "sentiment": "positive", "sentiment_pct": 62, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Beta Bionics Investor Alert: Johnson Fistel Reviews Potential Claims for Shareholders", "summary": "Johnson Fistel, PLLP is investigating Beta Bionics, Inc. (NASDAQ: BBNX) for potential securities law violations, focusing on whether the company made misleading statements regarding its growth and operating metrics. This investigation comes after Beta Bionics reported Q4 2025 new", "url": "https://www.prnewswire.com/news-releases/beta-bionics-investor-alert-johnson-fistel-reviews-potential-claims-for-shareholders-302816020.html", "source_name": "PR Newswire", "published_at": "2026-07-01T15:40:38", "published_display": "01 Jul 2026 15:40", "sentiment": "negative", "sentiment_pct": 19, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Beta Bionics (BBNX) CFO sells 10,000 shares under 10b5-1 trading plan", "summary": "Beta Bionics, Inc. (BBNX) Chief Financial Officer Stephen Feider sold 10,000 shares of common stock in open-market transactions between June 26 and June 29, 2026, at weighted average prices around $17.04. These sales were conducted under a pre-arranged Rule 10b5-1 trading plan ad", "url": "https://www.stocktitan.net/sec-filings/BBNX/form-4-beta-bionics-inc-insider-trading-activity-2f43d1166a87.html", "source_name": "Stock Titan", "published_at": "2026-07-01T09:39:23", "published_display": "01 Jul 2026 09:39", "sentiment": "negative", "sentiment_pct": 41, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "$BBNX stock is down 9% today. Here's what we see in our data.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxQWmxFb05xNGtiS2t3VDhpc3FRNENkUXgyZnhHQU42c1NKU1ZSZGM1LW5OcDU5eWhIdWQ3NjJSVkU0eEtTcmozTGtMZkt4OWpwMFd2MkZtemtXWjV2SlZYaFVBQWhmQXZsRFd4eFdCQzg5cERocVFSNUZ2R1RnSEh3cjRSVUVLUENWTXN3ajRzSXJNXzZfbkpXTWU1eUJjcFhkZkE?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-06-30T19:18:00+00:00", "published_display": "30 Jun 2026 19:18", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Beta Bionics: Some Stabilization In Sight (NASDAQ:BBNX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxPTVVCZUZ1VjF0UUlMeHgtWkdYNDVnTHJMcWd4dllDQWwzN0Vfa2x5d1EwSElLYzZMc09abGI3X0Vfc3hfRVR4em9VM0RSdVRLdXJZN2x1NUJwOE5OVUl4VEdqTktDQ3NqMWprVk9FVzZMTHFsajBkX2ZnRnBvcExwdVdXSEdnVW1C?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 144 Beta Bionics For: 29 June By Investing.com", "summary": "This article announces the filing of Form 144 for Beta Bionics on June 29. It provides stock market data, including various indices, commodities, and individual stock performances, alongside a list of popular news articles from Investing.com. The information is presented as a sna", "url": "https://ca.investing.com/news/stock-market-news/form-144-beta-bionics-for-29-june-93CH-4712289", "source_name": "Investing.com Canada", "published_at": "2026-06-29T18:41:28", "published_display": "29 Jun 2026 18:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BBNX (NASDAQ: BBNX) notice: proposed sale of 4,896 shares on 06/29/2026", "summary": "BBNX (NASDAQ: BBNX) has filed a Form 144 notice for the proposed sale of 4,896 shares of Common Stock, identified as stock options, to be sold for cash on June 29, 2026. The filing indicates 44,561,695 shares outstanding as of the same date. Additionally, it records prior sales b", "url": "https://www.stocktitan.net/sec-filings/BBNX/144-beta-bionics-inc-sec-filing-e8dd7b024dc6.html", "source_name": "Stock Titan", "published_at": "2026-06-29T17:41:28", "published_display": "29 Jun 2026 17:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Beta Bionics, Inc.(NasdaqGM: BBNX) dropped from Russell 2000 Growth Benchmark", "summary": "Beta Bionics, Inc. (BBNX) has been removed from the Russell 2000 Growth Benchmark. The medical device company, known for its iLet Bionic Pancreas for diabetes management, also saw its shares drop +1.07% on the day this news was published. This change in index inclusion follows se", "url": "https://www.marketscreener.com/news/beta-bionics-inc-nasdaqgm-bbnx-dropped-from-russell-2000-growth-benchmark-ce7f5fded18dfe2d", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T07:36:00", "published_display": "29 Jun 2026 07:36", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Beta Bionics, Inc.(NasdaqGM: BBNX) dropped from Russell 2500 Growth Benchmark", "summary": "Beta Bionics, Inc. (BBNX) has been removed from the Russell 2500 Growth Benchmark, as announced on June 28, 2026. This follows other recent removals from the Russell 2000 Growth, Russell 3000E Growth, and Russell 3000 Growth benchmarks. The company is a medical device firm focuse", "url": "https://www.marketscreener.com/news/beta-bionics-inc-nasdaqgm-bbnx-dropped-from-russell-2500-growth-benchmark-ce7f5fdfdf8df02d", "source_name": "marketscreener.com", "published_at": "2026-06-28T10:09:05", "published_display": "28 Jun 2026 10:09", "sentiment": "negative", "sentiment_pct": 19, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Beta Bionics (BBNX) CCO logs 1,258-share Rule 10b5-1 stock sale", "summary": "Beta Bionics' Chief Commercial Officer, Mark Hopman, reported an open-market sale of 1,258 shares of common stock on June 24, 2026. The sale, conducted under a pre-arranged Rule 10b5-1 Plan adopted in May 2025, occurred at a weighted average price of $15.0083 per share. Following", "url": "https://www.stocktitan.net/sec-filings/BBNX/form-4-beta-bionics-inc-insider-trading-activity-1c48e2b26e81.html", "source_name": "Stock Titan", "published_at": "2026-06-26T08:10:48", "published_display": "26 Jun 2026 08:10", "sentiment": "negative", "sentiment_pct": 40, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director Christy Jones sells BBNX shares under Rule 10b5-1 plan", "summary": "Beta Bionics director Christy Jones sold 1,406 shares of BBNX Common Stock at $15.00 per share under a pre-arranged Rule 10b5-1 trading plan adopted on February 19, 2026. Following this transaction, she now directly holds 25,994 shares. The sale, valued at $21,090, was disclosed ", "url": "https://www.stocktitan.net/sec-filings/BBNX/form-4-beta-bionics-inc-insider-trading-activity-97aa6e6bc4dc.html", "source_name": "Stock Titan", "published_at": "2026-06-26T08:10:48", "published_display": "26 Jun 2026 08:10", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BBNX Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast and price target for Beta Bionics, Inc. (BBNX) for 2027, based on analyst opinions. It details the company's financial performance, including past earnings and revenue, future earnings report dates, and key financial metrics like EBITDA. The artic", "url": "https://www.tradingview.com/symbols/BOATS-BBNX/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-26T07:11:03", "published_display": "26 Jun 2026 07:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Beta Bionics, Inc. Actuals & Estimates (BOATS:BBNX)", "summary": "This article provides an overview of Beta Bionics, Inc.'s (BBNX) financial actuals, estimates, and analyst forecasts. It covers details like stock tickers, price targets, historical highs and lows, upcoming earnings dates, recent earnings per share and revenue figures, net income", "url": "https://www.tradingview.com/symbols/BOATS-BBNX/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T07:10:22", "published_display": "26 Jun 2026 07:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Beta Bionics director Christy Jones sells $21,090 in stock", "summary": "Beta Bionics director Christy Jones sold 1,406 shares of the company\u2019s common stock for $21,090 on June 24, 2026, as part of a pre-planned trading arrangement. This transaction occurred amidst a 52.6% decline in Beta Bionics stock over the past six months, even though the company", "url": "https://www.investing.com/news/insider-trading-news/beta-bionics-director-christy-jones-sells-21090-in-stock-93CH-4761557", "source_name": "Investing.com", "published_at": "2026-06-26T00:10:04", "published_display": "26 Jun 2026 00:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "10b5-1 sales reported for BBNX insider Christina Jones (NASDAQ: BBNX)", "summary": "BBNX insider Christina Jones filed a Form 144 reporting planned and recent Rule 10b5-1 sales of restricted stock units. The filing details sales on May 21, 2026, and June 4, 2026, with specific amounts, and relates to Restricted Stock Units dated September 1, 2025. This document ", "url": "https://www.stocktitan.net/sec-filings/BBNX/144-beta-bionics-inc-sec-filing-19394f4c11ab.html", "source_name": "Stock Titan", "published_at": "2026-06-25T20:09:16", "published_display": "25 Jun 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lake Street Maintains Beta Bionics(BBNX.US) With Buy Rating, Maintains Target Price $20", "summary": "Lake Street has reiterated its Buy rating for Beta Bionics (BBNX.US), maintaining a target price of $20. This indicates a continued positive outlook from the analyst firm regarding the company's stock performance.", "url": "https://www.moomoo.com/news/post/71970743/lake-street-maintains-beta-bionics-bbnxus-with-buy-rating-maintains", "source_name": "Moomoo", "published_at": "2026-06-25T07:10:04", "published_display": "25 Jun 2026 07:10", "sentiment": "positive", "sentiment_pct": 80, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Undervalued Medical-Devices Stock Is Poised for a Rebound", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPN1g2RjVsUTVvTmdXRTdJMTRpVTlOQnZIbm9hTWJDdkRaeVpINjFqbXpDUVFpMVdYMExyR2VQQVNpZ3p0V2F1SVJMelpJZWk1bExvb0dYWnJ4VVJJRURseEVQVVZwNnRZREZiQzlFTHlhSHFadGdXRmpxbXA2XzBMNA?oc=5", "source_name": "Barron's", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNTWR3bzJReVB0UTNleWx6WDlmRW1rYmpLdkptZHdadzVERk1hTzdEV0M1Z2tuRUx2cldOT2d3WlVDank5Y01EWWFfWXdWNkJFdkNFcnhjMjdCQ1Y2aFBVbndiNXVBY0F5dDRpU2Fla25fVWRTUlNROXFwYXNXT2czUm5Nbl9QUFhFTEhHd1ZKTzJUSzhJWjN6QnNNUEVBTVEyR0l6YkZacUVsdw?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Have Beta Bionics Insiders Been Selling Stock?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UNH stock jumps on Q1 earnings beat and raised guidance to $18.25+", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPTEprdzNMNGZxdkg5Wll5MTlvS1dheXQybm14TERTcGVzcHQzY0llOEpTa0dpZ1hGdHVyNWZ2cFFiWmZRdkl1aUp4YVlTMVJxSDRzaEdzRFB1cW93QzdhSmNxcEZDMWhGX2F0ODJFcjY1Mk1kMVhLNnVJSUhVMHZpRjRtTHo2cXBvbVJ3a05SWlJNMUdrSzFPbA?oc=5", "source_name": "eciks.org", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Beta Bionics (BBNX) director gets stock grant, sells 1,998 shares under plan", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxOMUstazhyOThpcmZrQThQZ0JzTzEtaGx3TVJvTURjQU85ZTNTeW81NEk0RnpkWjYwT0RzbEh5cWxNR29QZ3l3a2d3emZuUXRpMy1QTFE5bllqeks5UjZEZFVtSW1FUkZjVS1ETUxULXByS2dZSWxiUEpWTzUzSkwzU1BYYWZJZ0JlRGFLTzQ1bXhKbmh2bHZhVGp3dDRpY0NxWFkxdkZaQlpSUDZWNVNV?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Here's Why We're Not Too Worried About Beta Bionics' (NASDAQ:BBNX) Cash Burn Situation", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxNR1k5WW9ybkxMNmxNd0tQODZnMmlKSWk0MHU4LTVxOGxhRG1Hcy1fNS1udEM2STRyOEY0M1NIZVFBLUpid1lfVDBmd1BuYVBvOFVBZ0ZGQ3pjU0Ria3EyT3hDd3N6cmI2OVlSR0UyYWhzZGRDWHYyUWZiQmJUUS1GMFNZQWluYjNsRXBrMjVYZC0?oc=5", "source_name": "Market source", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Diversified Stocks Q1 Results: Benchmarking Stryker (NYSE:SYK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNb1NaVXV6UW42emtDUzh5ckhKVjc2X29fSlFRRDVIVnRLWXpoWEYxUnVKNGZuLVN6ZWhxVno1SGluMEdLcmNrOGN1ZjlsWFpVRWxYbW9aYy01VFFpVzlncWtBYzF3YkJfNzhwTi1BcWlpVF9pUTU4QnNGWkJSV3YwRXVCUzk2Z2NUMWFjVkJOV2hSbFRrRnIxSWxNUGRoQmhQeDVBRjhYSnhvMDJqUThjYjBHRjhTRTBDdDZJd1k3LU5DTjU2cUx6TXFNdHhVS1FfdlFmaWZLNk41cFk?oc=5", "source_name": "StockStory", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "GE HealthCare (NASDAQ:GEHC) Posts Better-Than-Expected Sales In Q1 CY2026 But Stock Drops", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxOUjRRb0hlcHlOazlmelFaVVJSQWNnRmExZVBEQW1HMmVLTjNyU3d4WElsU05hdGlfYWFSY0twMTNWOVVCY0h4U2dYQ19BQl9pa3o0NWNBLW50WmFsSEVHdmJFV3JabnN5MFZpUWZabjZzY2tjMUtxbndONm9DS3NxTUp3Qjg2dWZnMDR2NXZ2eU80MWhSODVKdVgxZVJ6TWs3RFpCaDFqMXVtVkhmRVlOcWtqYUV1X1FPcGpfdERhRmwzdkZDaWxtSnJnd25Oam4yTnFHTFBkZi0tM1BZdkE?oc=5", "source_name": "StockStory", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Abbott is the most oversold healthcare stock as Q1 earnings roll on (XLV:NYSEARCA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOc2thQjFpazgwaFRfS3NjVXhlTkdFWHNFb240S0Z6akFtQXFIMmFmaXZnQ1A3OFVCQW9DT25OLVBQdGN5Yk52Mk9yUFlSX19ZS3FRTjZoR05zc2FVc25pVHQ0TDVHT2JmVnJabGNCREdLT2stV0IzLVdHWXpFZGU3V1NnVGhYbFRzNURVek41TVRmLWZQZTFYUkc4aXM0a1cwTkNFYTBfVnQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Beta Bionics Inc. (BBNX) Stock Rises on Q1 2026 Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxOR1dnTU1NSHJnTHFSRUl5TzJLS2JRS200QjFWRnJwR1UtRXdPVDVGcE1FWkJwUTJ2V1I5V2hHS1hVVWNyRURBN3ZuTUYyTlNFLXlia2oxWWxsejBaSTdPQ1pXRHNLVDdueEktSDdaUnVscWd1WTQxTlpjbWVjdWNJSzFQY3JlYUdNQ2FyX0dudlo1UC1lLTZmTg?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Beta Bionics, Inc. (BBNX) Reports Q1 Loss, Misses Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNODEzMWRYNFVSdnVsSEY0TFVlekZqbDdTemZmaTVuVVMySmduOUY2V1hDcHdSWmtLUVlRQW4wVnAzZjVVUVlITHFZb19UbEtwN1ZJLTBBM0JmTk5ySzhuczQzcE8zT2xPX2owOTYzTUx2bi1xOU9td194VlR5Zk85NElUZ01zcnRHX000T1NVd3poVjE5dW5INTJ6ME1vWTg?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "negative", "sentiment_pct": 18, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Baxter (NYSE:BAX) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxOb3BiQVNFREdNblk2QS10b1lhRUtfb05vU2VFZHB5V0hJT0R4NmhwQWRrcFVsR3UwMjZleFV6N2FEelpZVzY3YWFxSWE1cWpLaTFrQVU4NktkQUloUkxaV3ZTVkh6b1ZmaDdMN2ViX1BUNE4xUTNUZFNlR0syVGlZSg?oc=5", "source_name": "Market source", "published_at": "2026-03-02T08:00:00+00:00", "published_display": "02 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Beta Bionics, Inc.'s (NASDAQ:BBNX) Popularity With Investors Under Threat As Stock Sinks 58%", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-06T08:00:00+00:00", "published_display": "06 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UnitedHealth Stock Plummets 20% After Earnings. Why Soft Revenue Isn\u2019t the Only Problem.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggFBVV95cUxPMTdzUkZQWG9tTW9zT3FxSWtzdkdLLUNYVkRJMDh2X1VRSlVrdmVkS3FCSVFpX210VUxVSUF1Q2FYakw1ZUxyQlpoZHZpM1RYQzBOYlpEWENxeGM1bXBZNFYxQjZRcFBpcS0tVVhRdzFTejBrVzU3aU9QQXdnYkZBMWxB?oc=5", "source_name": "Barron's", "published_at": "2026-01-27T08:00:00+00:00", "published_display": "27 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "$BBNX stock is down 36% today. Here's what we see in our data.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxQMXd3N0xVZDY2eVMxZ1I0cW1LMGZvSU16WkFlSkdPNFdzQ1RScTBsOGg4cS11V2xFZC0wNFRKTUpsSGdoY09zdm0wYXV0V2h0UThWZTZtejlwTEdGTlcwS3JtMHg4TGFWOGRJdnFyd0pfX0dEMEtUamlEUjBDZTZhZjdpTndYTnZoRjY4NGZ1UEtyZHJBd1RGNVhyU2NzdzV2TWRn?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-01-09T08:00:00+00:00", "published_display": "09 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Beta Bionics stock tumbles following deceleration in new patient starts", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxNN3k1bzY0SkpKcDhvX3lrS1h5RVNueTNQOG1HaWRmdVYtdFVjb1M5UHVsWGF4SGdKMUhQc0JFR3M2dTg0Z0w5TnNHMmlBdnM4ZzBRdzhqUl9STGpUY0hOd0k3RmpSSkZId3ZHV2pkNTkwZ0xRMFpVSzRnakdrclM3ZkNwRlRZc0tWbFFEM2V6VTlRckZiV0JUNy02cF85ajVyV1o3Ni1NSl9MTjJpRVRxcnJUc055eEN2UGpqdWE0VUdxOWNPa1RVMFJoLWtDQQ?oc=5", "source_name": "Investing.com", "published_at": "2026-01-09T08:00:00+00:00", "published_display": "09 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BBNX Stock May Gain From Abbott Deal to Advance iLet Integration", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxNMFhYTGF1d2R4VVR0SGJoY0M5Z0M4MTJpX21oNi05a2MtYmVKcEd1ZnVxa29GWGdwdHFBQXhRQ1lwRThERmVWZmJHTjRzVHNNV3hrNFJ4SDF5MmtUSk0xOTZmcW9McjcyNHl1OXl6WWpFWEdrd1NlQ04xWEhvVU1DcUJRZHNOMVNScjh3MWZCVUdWcWc1WlE0LUVSbEtxOTktenlvOXlocEFCN0J5Mjl1TnNfeVh4bVcybzNGOA?oc=5", "source_name": "TradingView", "published_at": "2025-06-23T07:00:00+00:00", "published_display": "23 Jun 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Truist Raises Price Target on Beta Bionics to $22 From $18, Keeps Buy Rating", "summary": "Truist Securities has increased its price target for Beta Bionics (NASDAQ: BBLN) to $22 from $18, while reiterating a \"Buy\" rating on the stock. This adjustment suggests a positive outlook on the company's financial prospects and stock performance.", "url": "https://www.moomoo.com/news/post/72857299/truist-raises-price-target-on-beta-bionics-to-22-from?futusource=news_newspage_recommend", "source_name": "Moomoo", "published_at": "2026-07-14T14:13:43", "published_display": "14 Jul 2026 14:13", "sentiment": "positive", "sentiment_pct": 73, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "If You Invested $1,000 in Beta Bionics, Inc. (BBNX)", "summary": "This article analyzes the historical performance of Beta Bionics, Inc. (BBNX) stock, specifically calculating the return on a hypothetical $1,000 investment over different periods. It highlights that a $1,000 investment one year ago would now be worth $1,346, a 34.6% increase. Th", "url": "https://www.stocktitan.net/tools/stock-return-calculator/BBNX", "source_name": "Stock Titan", "published_at": "2026-07-14T14:13:43", "published_display": "14 Jul 2026 14:13", "sentiment": "positive", "sentiment_pct": 63, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ETFs Investing in Beta Bionics, Inc. Stocks", "summary": "This article lists several ETFs that invest in Beta Bionics, Inc. (BBNX) stocks, providing details such as market value, weight, issuer, expense ratio, and performance. The ETFs offer investors diversified exposure to the medical technology sector and small-cap companies, among o", "url": "https://www.tradingview.com/symbols/NASDAQ-BBNX/etfs/", "source_name": "TradingView", "published_at": "2026-07-07T20:13:13", "published_display": "07 Jul 2026 20:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Beta Bionics, Inc. \u2013 NASDAQ:BBNX", "summary": "This article focuses on the \"Price to earnings forward\" financial metric for Beta Bionics, Inc. (NASDAQ: BBNX) as reported by TradingView. The page displays the company's stock information, along with navigation to various financial and community features on the TradingView platf", "url": "https://www.tradingview.com/symbols/NASDAQ-BBNX/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-07-06T09:40:08", "published_display": "06 Jul 2026 09:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Beta Bionics, Inc. \u2013 NASDAQ:BBNX", "summary": "This article provides financial data for Beta Bionics, Inc. (NASDAQ: BBNX), specifically focusing on its enterprise value to EBITDA forward metric. The content appears to be a financial data snippet from TradingView, indicating the period, value, and change for this specific fina", "url": "https://www.tradingview.com/symbols/NASDAQ-BBNX/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-07-04T11:10:06", "published_display": "04 Jul 2026 11:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Beta Bionics CFO Stephen Feider sells $170k of BBNX stock", "summary": "Stephen Feider, CFO of Beta Bionics (NASDAQ:BBNX), sold 10,000 shares of company stock for a total of approximately $170,387 across two transactions in late June. These sales were made under a Rule 10b5-1 trading plan and occurred concurrently with the exercise of employee stock ", "url": "https://www.investing.com/news/insider-trading-news/beta-bionics-cfo-stephen-feider-sells-170k-of-bbnx-stock-93CH-4774658", "source_name": "Investing.com", "published_at": "2026-07-02T23:12:55", "published_display": "02 Jul 2026 23:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Beta Bionics to Announce Second Quarter 2026 Financial Results on July 29, 2026", "summary": "Beta Bionics, Inc. announced its plan to release second quarter 2026 financial results after market close on Wednesday, July 29, 2026. The company will host a conference call and webcast on the same day at 4:30 pm Eastern Time to discuss its performance. The webcast link and dial", "url": "https://www.manilatimes.net/2026/07/01/tmt-newswire/globenewswire/beta-bionics-to-announce-second-quarter-2026-financial-results-on-july-29-2026/2376712", "source_name": "The Manila Times", "published_at": "2026-07-02T10:40:42", "published_display": "02 Jul 2026 10:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Beta Bionics sets July 29 call for Q2 2026 results", "summary": "Beta Bionics (Nasdaq: BBNX) announced it will release its second quarter 2026 financial results after market close on Wednesday, July 29, 2026. Management will host a conference call and webcast on the same day at 4:30 pm ET to discuss the quarterly performance. The announcement ", "url": "https://www.stocktitan.net/news/BBNX/beta-bionics-to-announce-second-quarter-2026-financial-results-on-w0nxe80bjo0u.html", "source_name": "Stock Titan", "published_at": "2026-07-01T23:40:47", "published_display": "01 Jul 2026 23:40", "sentiment": "positive", "sentiment_pct": 62, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Beta Bionics Investor Alert: Johnson Fistel Reviews Potential Claims for Shareholders", "summary": "Johnson Fistel, PLLP is investigating Beta Bionics, Inc. (NASDAQ: BBNX) for potential securities law violations, focusing on whether the company made misleading statements regarding its growth and operating metrics. This investigation comes after Beta Bionics reported Q4 2025 new", "url": "https://www.prnewswire.com/news-releases/beta-bionics-investor-alert-johnson-fistel-reviews-potential-claims-for-shareholders-302816020.html", "source_name": "PR Newswire", "published_at": "2026-07-01T15:40:38", "published_display": "01 Jul 2026 15:40", "sentiment": "negative", "sentiment_pct": 19, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Beta Bionics (BBNX) CFO sells 10,000 shares under 10b5-1 trading plan", "summary": "Beta Bionics, Inc. (BBNX) Chief Financial Officer Stephen Feider sold 10,000 shares of common stock in open-market transactions between June 26 and June 29, 2026, at weighted average prices around $17.04. These sales were conducted under a pre-arranged Rule 10b5-1 trading plan ad", "url": "https://www.stocktitan.net/sec-filings/BBNX/form-4-beta-bionics-inc-insider-trading-activity-2f43d1166a87.html", "source_name": "Stock Titan", "published_at": "2026-07-01T09:39:23", "published_display": "01 Jul 2026 09:39", "sentiment": "negative", "sentiment_pct": 41, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "$BBNX stock is down 9% today. Here's what we see in our data.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxQWmxFb05xNGtiS2t3VDhpc3FRNENkUXgyZnhHQU42c1NKU1ZSZGM1LW5OcDU5eWhIdWQ3NjJSVkU0eEtTcmozTGtMZkt4OWpwMFd2MkZtemtXWjV2SlZYaFVBQWhmQXZsRFd4eFdCQzg5cERocVFSNUZ2R1RnSEh3cjRSVUVLUENWTXN3ajRzSXJNXzZfbkpXTWU1eUJjcFhkZkE?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-06-30T19:18:00+00:00", "published_display": "30 Jun 2026 19:18", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Beta Bionics: Some Stabilization In Sight (NASDAQ:BBNX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxPTVVCZUZ1VjF0UUlMeHgtWkdYNDVnTHJMcWd4dllDQWwzN0Vfa2x5d1EwSElLYzZMc09abGI3X0Vfc3hfRVR4em9VM0RSdVRLdXJZN2x1NUJwOE5OVUl4VEdqTktDQ3NqMWprVk9FVzZMTHFsajBkX2ZnRnBvcExwdVdXSEdnVW1C?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 144 Beta Bionics For: 29 June By Investing.com", "summary": "This article announces the filing of Form 144 for Beta Bionics on June 29. It provides stock market data, including various indices, commodities, and individual stock performances, alongside a list of popular news articles from Investing.com. The information is presented as a sna", "url": "https://ca.investing.com/news/stock-market-news/form-144-beta-bionics-for-29-june-93CH-4712289", "source_name": "Investing.com Canada", "published_at": "2026-06-29T18:41:28", "published_display": "29 Jun 2026 18:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BBNX (NASDAQ: BBNX) notice: proposed sale of 4,896 shares on 06/29/2026", "summary": "BBNX (NASDAQ: BBNX) has filed a Form 144 notice for the proposed sale of 4,896 shares of Common Stock, identified as stock options, to be sold for cash on June 29, 2026. The filing indicates 44,561,695 shares outstanding as of the same date. Additionally, it records prior sales b", "url": "https://www.stocktitan.net/sec-filings/BBNX/144-beta-bionics-inc-sec-filing-e8dd7b024dc6.html", "source_name": "Stock Titan", "published_at": "2026-06-29T17:41:28", "published_display": "29 Jun 2026 17:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Beta Bionics, Inc.(NasdaqGM: BBNX) dropped from Russell 2000 Growth Benchmark", "summary": "Beta Bionics, Inc. (BBNX) has been removed from the Russell 2000 Growth Benchmark. The medical device company, known for its iLet Bionic Pancreas for diabetes management, also saw its shares drop +1.07% on the day this news was published. This change in index inclusion follows se", "url": "https://www.marketscreener.com/news/beta-bionics-inc-nasdaqgm-bbnx-dropped-from-russell-2000-growth-benchmark-ce7f5fded18dfe2d", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T07:36:00", "published_display": "29 Jun 2026 07:36", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Beta Bionics, Inc.(NasdaqGM: BBNX) dropped from Russell 2500 Growth Benchmark", "summary": "Beta Bionics, Inc. (BBNX) has been removed from the Russell 2500 Growth Benchmark, as announced on June 28, 2026. This follows other recent removals from the Russell 2000 Growth, Russell 3000E Growth, and Russell 3000 Growth benchmarks. The company is a medical device firm focuse", "url": "https://www.marketscreener.com/news/beta-bionics-inc-nasdaqgm-bbnx-dropped-from-russell-2500-growth-benchmark-ce7f5fdfdf8df02d", "source_name": "marketscreener.com", "published_at": "2026-06-28T10:09:05", "published_display": "28 Jun 2026 10:09", "sentiment": "negative", "sentiment_pct": 19, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Beta Bionics (BBNX) CCO logs 1,258-share Rule 10b5-1 stock sale", "summary": "Beta Bionics' Chief Commercial Officer, Mark Hopman, reported an open-market sale of 1,258 shares of common stock on June 24, 2026. The sale, conducted under a pre-arranged Rule 10b5-1 Plan adopted in May 2025, occurred at a weighted average price of $15.0083 per share. Following", "url": "https://www.stocktitan.net/sec-filings/BBNX/form-4-beta-bionics-inc-insider-trading-activity-1c48e2b26e81.html", "source_name": "Stock Titan", "published_at": "2026-06-26T08:10:48", "published_display": "26 Jun 2026 08:10", "sentiment": "negative", "sentiment_pct": 40, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director Christy Jones sells BBNX shares under Rule 10b5-1 plan", "summary": "Beta Bionics director Christy Jones sold 1,406 shares of BBNX Common Stock at $15.00 per share under a pre-arranged Rule 10b5-1 trading plan adopted on February 19, 2026. Following this transaction, she now directly holds 25,994 shares. The sale, valued at $21,090, was disclosed ", "url": "https://www.stocktitan.net/sec-filings/BBNX/form-4-beta-bionics-inc-insider-trading-activity-97aa6e6bc4dc.html", "source_name": "Stock Titan", "published_at": "2026-06-26T08:10:48", "published_display": "26 Jun 2026 08:10", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BBNX Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast and price target for Beta Bionics, Inc. (BBNX) for 2027, based on analyst opinions. It details the company's financial performance, including past earnings and revenue, future earnings report dates, and key financial metrics like EBITDA. The artic", "url": "https://www.tradingview.com/symbols/BOATS-BBNX/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-26T07:11:03", "published_display": "26 Jun 2026 07:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Beta Bionics, Inc. Actuals & Estimates (BOATS:BBNX)", "summary": "This article provides an overview of Beta Bionics, Inc.'s (BBNX) financial actuals, estimates, and analyst forecasts. It covers details like stock tickers, price targets, historical highs and lows, upcoming earnings dates, recent earnings per share and revenue figures, net income", "url": "https://www.tradingview.com/symbols/BOATS-BBNX/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T07:10:22", "published_display": "26 Jun 2026 07:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Beta Bionics director Christy Jones sells $21,090 in stock", "summary": "Beta Bionics director Christy Jones sold 1,406 shares of the company\u2019s common stock for $21,090 on June 24, 2026, as part of a pre-planned trading arrangement. This transaction occurred amidst a 52.6% decline in Beta Bionics stock over the past six months, even though the company", "url": "https://www.investing.com/news/insider-trading-news/beta-bionics-director-christy-jones-sells-21090-in-stock-93CH-4761557", "source_name": "Investing.com", "published_at": "2026-06-26T00:10:04", "published_display": "26 Jun 2026 00:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "10b5-1 sales reported for BBNX insider Christina Jones (NASDAQ: BBNX)", "summary": "BBNX insider Christina Jones filed a Form 144 reporting planned and recent Rule 10b5-1 sales of restricted stock units. The filing details sales on May 21, 2026, and June 4, 2026, with specific amounts, and relates to Restricted Stock Units dated September 1, 2025. This document ", "url": "https://www.stocktitan.net/sec-filings/BBNX/144-beta-bionics-inc-sec-filing-19394f4c11ab.html", "source_name": "Stock Titan", "published_at": "2026-06-25T20:09:16", "published_display": "25 Jun 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lake Street Maintains Beta Bionics(BBNX.US) With Buy Rating, Maintains Target Price $20", "summary": "Lake Street has reiterated its Buy rating for Beta Bionics (BBNX.US), maintaining a target price of $20. This indicates a continued positive outlook from the analyst firm regarding the company's stock performance.", "url": "https://www.moomoo.com/news/post/71970743/lake-street-maintains-beta-bionics-bbnxus-with-buy-rating-maintains", "source_name": "Moomoo", "published_at": "2026-06-25T07:10:04", "published_display": "25 Jun 2026 07:10", "sentiment": "positive", "sentiment_pct": 80, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Undervalued Medical-Devices Stock Is Poised for a Rebound", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPN1g2RjVsUTVvTmdXRTdJMTRpVTlOQnZIbm9hTWJDdkRaeVpINjFqbXpDUVFpMVdYMExyR2VQQVNpZ3p0V2F1SVJMelpJZWk1bExvb0dYWnJ4VVJJRURseEVQVVZwNnRZREZiQzlFTHlhSHFadGdXRmpxbXA2XzBMNA?oc=5", "source_name": "Barron's", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Have Beta Bionics Insiders Been Selling Stock?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UNH stock jumps on Q1 earnings beat and raised guidance to $18.25+", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPTEprdzNMNGZxdkg5Wll5MTlvS1dheXQybm14TERTcGVzcHQzY0llOEpTa0dpZ1hGdHVyNWZ2cFFiWmZRdkl1aUp4YVlTMVJxSDRzaEdzRFB1cW93QzdhSmNxcEZDMWhGX2F0ODJFcjY1Mk1kMVhLNnVJSUhVMHZpRjRtTHo2cXBvbVJ3a05SWlJNMUdrSzFPbA?oc=5", "source_name": "eciks.org", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Beta Bionics (BBNX) director gets stock grant, sells 1,998 shares under plan", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxOMUstazhyOThpcmZrQThQZ0JzTzEtaGx3TVJvTURjQU85ZTNTeW81NEk0RnpkWjYwT0RzbEh5cWxNR29QZ3l3a2d3emZuUXRpMy1QTFE5bllqeks5UjZEZFVtSW1FUkZjVS1ETUxULXByS2dZSWxiUEpWTzUzSkwzU1BYYWZJZ0JlRGFLTzQ1bXhKbmh2bHZhVGp3dDRpY0NxWFkxdkZaQlpSUDZWNVNV?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here's Why We're Not Too Worried About Beta Bionics' (NASDAQ:BBNX) Cash Burn Situation", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxNR1k5WW9ybkxMNmxNd0tQODZnMmlKSWk0MHU4LTVxOGxhRG1Hcy1fNS1udEM2STRyOEY0M1NIZVFBLUpid1lfVDBmd1BuYVBvOFVBZ0ZGQ3pjU0Ria3EyT3hDd3N6cmI2OVlSR0UyYWhzZGRDWHYyUWZiQmJUUS1GMFNZQWluYjNsRXBrMjVYZC0?oc=5", "source_name": "Market source", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GE HealthCare (NASDAQ:GEHC) Posts Better-Than-Expected Sales In Q1 CY2026 But Stock Drops", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxOUjRRb0hlcHlOazlmelFaVVJSQWNnRmExZVBEQW1HMmVLTjNyU3d4WElsU05hdGlfYWFSY0twMTNWOVVCY0h4U2dYQ19BQl9pa3o0NWNBLW50WmFsSEVHdmJFV3JabnN5MFZpUWZabjZzY2tjMUtxbndONm9DS3NxTUp3Qjg2dWZnMDR2NXZ2eU80MWhSODVKdVgxZVJ6TWs3RFpCaDFqMXVtVkhmRVlOcWtqYUV1X1FPcGpfdERhRmwzdkZDaWxtSnJnd25Oam4yTnFHTFBkZi0tM1BZdkE?oc=5", "source_name": "StockStory", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott is the most oversold healthcare stock as Q1 earnings roll on (XLV:NYSEARCA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOc2thQjFpazgwaFRfS3NjVXhlTkdFWHNFb240S0Z6akFtQXFIMmFmaXZnQ1A3OFVCQW9DT25OLVBQdGN5Yk52Mk9yUFlSX19ZS3FRTjZoR05zc2FVc25pVHQ0TDVHT2JmVnJabGNCREdLT2stV0IzLVdHWXpFZGU3V1NnVGhYbFRzNURVek41TVRmLWZQZTFYUkc4aXM0a1cwTkNFYTBfVnQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Beta Bionics Inc. (BBNX) Stock Rises on Q1 2026 Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxOR1dnTU1NSHJnTHFSRUl5TzJLS2JRS200QjFWRnJwR1UtRXdPVDVGcE1FWkJwUTJ2V1I5V2hHS1hVVWNyRURBN3ZuTUYyTlNFLXlia2oxWWxsejBaSTdPQ1pXRHNLVDdueEktSDdaUnVscWd1WTQxTlpjbWVjdWNJSzFQY3JlYUdNQ2FyX0dudlo1UC1lLTZmTg?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Beta Bionics, Inc. (BBNX) Reports Q1 Loss, Misses Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNODEzMWRYNFVSdnVsSEY0TFVlekZqbDdTemZmaTVuVVMySmduOUY2V1hDcHdSWmtLUVlRQW4wVnAzZjVVUVlITHFZb19UbEtwN1ZJLTBBM0JmTk5ySzhuczQzcE8zT2xPX2owOTYzTUx2bi1xOU9td194VlR5Zk85NElUZ01zcnRHX000T1NVd3poVjE5dW5INTJ6ME1vWTg?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "negative", "sentiment_pct": 18, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Beta Bionics, Inc.'s (NASDAQ:BBNX) Popularity With Investors Under Threat As Stock Sinks 58%", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-06T08:00:00+00:00", "published_display": "06 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UnitedHealth Stock Plummets 20% After Earnings. Why Soft Revenue Isn\u2019t the Only Problem.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggFBVV95cUxPMTdzUkZQWG9tTW9zT3FxSWtzdkdLLUNYVkRJMDh2X1VRSlVrdmVkS3FCSVFpX210VUxVSUF1Q2FYakw1ZUxyQlpoZHZpM1RYQzBOYlpEWENxeGM1bXBZNFYxQjZRcFBpcS0tVVhRdzFTejBrVzU3aU9QQXdnYkZBMWxB?oc=5", "source_name": "Barron's", "published_at": "2026-01-27T08:00:00+00:00", "published_display": "27 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "$BBNX stock is down 36% today. Here's what we see in our data.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxQMXd3N0xVZDY2eVMxZ1I0cW1LMGZvSU16WkFlSkdPNFdzQ1RScTBsOGg4cS11V2xFZC0wNFRKTUpsSGdoY09zdm0wYXV0V2h0UThWZTZtejlwTEdGTlcwS3JtMHg4TGFWOGRJdnFyd0pfX0dEMEtUamlEUjBDZTZhZjdpTndYTnZoRjY4NGZ1UEtyZHJBd1RGNVhyU2NzdzV2TWRn?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-01-09T08:00:00+00:00", "published_display": "09 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Beta Bionics stock tumbles following deceleration in new patient starts", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxNN3k1bzY0SkpKcDhvX3lrS1h5RVNueTNQOG1HaWRmdVYtdFVjb1M5UHVsWGF4SGdKMUhQc0JFR3M2dTg0Z0w5TnNHMmlBdnM4ZzBRdzhqUl9STGpUY0hOd0k3RmpSSkZId3ZHV2pkNTkwZ0xRMFpVSzRnakdrclM3ZkNwRlRZc0tWbFFEM2V6VTlRckZiV0JUNy02cF85ajVyV1o3Ni1NSl9MTjJpRVRxcnJUc055eEN2UGpqdWE0VUdxOWNPa1RVMFJoLWtDQQ?oc=5", "source_name": "Investing.com", "published_at": "2026-01-09T08:00:00+00:00", "published_display": "09 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BBNX Stock May Gain From Abbott Deal to Advance iLet Integration", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxNMFhYTGF1d2R4VVR0SGJoY0M5Z0M4MTJpX21oNi05a2MtYmVKcEd1ZnVxa29GWGdwdHFBQXhRQ1lwRThERmVWZmJHTjRzVHNNV3hrNFJ4SDF5MmtUSk0xOTZmcW9McjcyNHl1OXl6WWpFWEdrd1NlQ04xWEhvVU1DcUJRZHNOMVNScjh3MWZCVUdWcWc1WlE0LUVSbEtxOTktenlvOXlocEFCN0J5Mjl1TnNfeVh4bVcybzNGOA?oc=5", "source_name": "TradingView", "published_at": "2025-06-23T07:00:00+00:00", "published_display": "23 Jun 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNTWR3bzJReVB0UTNleWx6WDlmRW1rYmpLdkptZHdadzVERk1hTzdEV0M1Z2tuRUx2cldOT2d3WlVDank5Y01EWWFfWXdWNkJFdkNFcnhjMjdCQ1Y2aFBVbndiNXVBY0F5dDRpU2Fla25fVWRTUlNROXFwYXNXT2czUm5Nbl9QUFhFTEhHd1ZKTzJUSzhJWjN6QnNNUEVBTVEyR0l6YkZacUVsdw?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Diversified Stocks Q1 Results: Benchmarking Stryker (NYSE:SYK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNb1NaVXV6UW42emtDUzh5ckhKVjc2X29fSlFRRDVIVnRLWXpoWEYxUnVKNGZuLVN6ZWhxVno1SGluMEdLcmNrOGN1ZjlsWFpVRWxYbW9aYy01VFFpVzlncWtBYzF3YkJfNzhwTi1BcWlpVF9pUTU4QnNGWkJSV3YwRXVCUzk2Z2NUMWFjVkJOV2hSbFRrRnIxSWxNUGRoQmhQeDVBRjhYSnhvMDJqUThjYjBHRjhTRTBDdDZJd1k3LU5DTjU2cUx6TXFNdHhVS1FfdlFmaWZLNk41cFk?oc=5", "source_name": "StockStory", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Baxter (NYSE:BAX) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxOb3BiQVNFREdNblk2QS10b1lhRUtfb05vU2VFZHB5V0hJT0R4NmhwQWRrcFVsR3UwMjZleFV6N2FEelpZVzY3YWFxSWE1cWpLaTFrQVU4NktkQUloUkxaV3ZTVkh6b1ZmaDdMN2ViX1BUNE4xUTNUZFNlR0syVGlZSg?oc=5", "source_name": "Market source", "published_at": "2026-03-02T08:00:00+00:00", "published_display": "02 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 89, "total_relevant": 49, "sentiment_summary": {"positive": 6, "negative": 7, "neutral": 36, "score": 50, "total": 49, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 76, "events": [{"event": "general", "label": "Market update", "weight": 12.25, "count": 21}, {"event": "earnings", "label": "Earnings", "weight": 11.15, "count": 22}, {"event": "analyst", "label": "Analyst action", "weight": 1.1, "count": 2}, {"event": "liquidity", "label": "Balance sheet", "weight": 1.1, "count": 2}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}], "positive_events": 6, "negative_events": 7}, "market_context": {"has_market_context": true, "latest_close": 17.03, "latest_week": "2026-07-10", "one_week_move": 1.6, "four_week_move": 17.2, "twelve_week_move": 31.2, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.979166, "market_dynamics_buy_signal": false, "relative_strength": -19.213339, "fair_value_gap": -1.4, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 49.0909, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+1.6% over one week, +17.2% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 57, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 12}, {"label": "Stock Titan", "count": 8}, {"label": "TradingView", "count": 6}, {"label": "Investing.com", "count": 3}, {"label": "Quiver Quantitative", "count": 3}, {"label": "StockStory", "count": 3}, {"label": "Moomoo", "count": 2}, {"label": "Seeking Alpha", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 37}, {"label": "Industry context", "count": 12}, {"label": "Sector context", "count": 0}], "events": [{"label": "Earnings", "count": 22}, {"label": "Market update", "count": 21}, {"label": "Analyst action", "count": 2}, {"label": "Balance sheet", "count": 2}, {"label": "Regulatory and legal", "count": 1}, {"label": "Deals and strategy", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "76/100 classification confidence."}, {"label": "Company focus", "value": "37", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "4", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+1.6% over one week, +17.2% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "Truist Raises Price Target on Beta Bionics to $22 From $18, Keeps Buy Rating"}], "updated_at": "2026-07-16T05:41:42.281962+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}